US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Cuprina Holdings (Cayman) Limited

0.4163

-0.0110-2.57%

Post-market: 0.41630.00000.00%19:16 EST

Volume:27.85K

Turnover:11.52K

Market Cap:8.93M

PE:-4.00

High:0.4268

Open:0.4197

Low:0.4000

Close:0.4273

52wk High:9.50

52wk Low:0.3760

Shares:21.45M

Float Shares:7.36M

Volume Ratio:0.35

T/O Rate:0.38%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.1040

EPS(LYR):-0.0635

ROE:-139.10%

ROA:-28.44%

PB:1.48

PE(LYR):-6.55

Loading ...

Overview Company News Filings

Cuprina Holdings Forms Joint Venture With Aiodine Laboratory for Iodine-Based Wound Treatments

Cuprina Holdings (Cayman) Limited Announces Financial Results for the Six Months Ended June 30, 2025, and Strategic Initiatives for 2026 Growth

Cuprina Holdings (Cayman) Limited Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency

Cuprina Forms Joint Venture Company With Aiodine Laboratory To Develop And Market Novel Iodine-Based Solution As New Wound Care Therapy

Cuprina Holdings Forms Joint Venture with Aiodine Laboratory to Develop Iodine-Based Wound Care Solution

Cuprina Holdings (Cayman) Ltd - Clinical Studies for Regulatory Approvals Planned for 2026

THOMSON REUTERS

BRIEF-Cuprina Signs MoU With Singapore Biowaste Solutions To Integrate Medical Waste Management Technologies

Cuprina Signs Mou With Singapore Biowaste Solutions to Integrate Medical Waste Management Technologies

THOMSON REUTERS

Cuprina Holdings (Cayman) Ltd. to Present and Answer Investor Questions Live at Skyline Signature Series™ Event

Nasdaq Surges Over 100 Points; Chewy Shares Fall After Q2 Results

Cuprina Holdings (Cayman) Ltd: License With Zhejiang Heliang Covers Singapore + Option for 10 Sea Countries

THOMSON REUTERS

Cuprina Holdings (Cayman) Ltd: Secures Exclusive Rights to Southeast Asia’s First Medical Waste Recycling Technology

THOMSON REUTERS

Cuprina Holdings Secures Exclusive Rights to Pioneering Medical Waste Recycling Technology in Southeast Asia

Cuprina Holdings (Cayman) Ltd - Unaware of Reasons for Stock Volatility

THOMSON REUTERS

Cuprina Holdings (Cayman) Ltd - Responds to UnUsUaL Trading Activity

THOMSON REUTERS

Cuprina Holdings (Cayman) Ltd. reagiert auf jüngste Kursbewegungen der eigenen Aktie

BUZZ-U.S. STOCKS ON THE MOVE-Xcel Energy, Opendoor Technologies, Advance Auto Parts

Cuprina Signs Agreement to Market Medical Maggots for Debridement Therapy in US

MT Newswires Live

Cuprina Holdings Appoints Dr. Ronald Sherman as Medical and Scientific Director, Enhancing Leadership in Maggot Debridement Therapy

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/CUPR/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CUPR","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CUPR\",,,,,undefined,":{"symbol":"CUPR","market":"US","secType":"STK","nameCN":"Cuprina Holdings (Cayman) Limited","latestPrice":0.4163,"timestamp":1770411600000,"preClose":0.4273,"halted":0,"volume":27849,"hourTrading":{"tag":"盘后","latestPrice":0.4163,"preClose":0.4163,"latestTime":"19:16 EST","volume":59,"amount":24.5617,"timestamp":1770423412570,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.02574303767844608,"floatShares":7364999,"shares":21450000,"eps":-0.104,"marketStatus":"Market Closed","change":-0.011,"latestTime":"02-06 16:00:00 EST","open":0.4197,"high":0.4268,"low":0.4,"amount":11523.33276345,"amplitude":0.062719,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.104,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1770627600000},"marketStatusCode":7,"adr":0,"listingDate":1724644800000,"exchange":"NASDAQ","adjPreClose":0.4273,"postHourTrading":{"tag":"盘后","latestPrice":0.4163,"preClose":0.4163,"latestTime":"19:16 EST","volume":59,"amount":24.5617,"timestamp":1770423412570,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.345671},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CUPR\",,,,,undefined,":{"symbol":"CUPR","floatShares":7364999,"roa":"-28.44%","roe":"-139.10%","lyrEps":-0.063525,"volumeRatio":0.345671,"shares":21450000,"dividePrice":0,"high":0.4268,"amplitude":0.062719,"preClose":0.4273,"low":0.4,"week52Low":0.376,"pbRate":"1.48","psRate":"374.75","week52High":9.5,"institutionHeld":0,"latestPrice":0.4163,"eps":-0.104,"divideRate":0,"volume":27849,"delay":0,"ttmEps":-0.104,"open":0.4197,"prevYearClose":0.4001,"prevWeekClose":0.4228,"prevMonthClose":0.4228,"prevQuarterClose":0.4001},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CUPR\",params:#limit:5,,,undefined,":[{"date":"2025-12-09","symbol":"CUPR","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1765270800000,"name":null,"time":"Pre-Market","dateTimestamp":1765256400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CUPR\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CUPR\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CUPR\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CUPR","date":"2026-02-05","current":-4.002885,"percent":0.985366,"low":-165.960185,"twenty":-102.288908,"median":-19.551508,"eighty":-11.313324,"high":-3.705441,"avg":-53.971486,"sd":50.773046,"marketCap":8910330},"quantilePoints":[{"date":"2025-04-11","current":-84.622272,"twenty":-84.622272,"median":-84.622272,"eighty":-84.622272,"marketCap":87150000},{"date":"2025-04-17","current":-113.715976,"twenty":-101.078226,"median":-91.9774,"eighty":-89.161662,"marketCap":118920000},{"date":"2025-04-25","current":-91.46624,"twenty":-98.116219,"median":-93.732067,"eighty":-91.168717,"marketCap":95550000},{"date":"2025-05-02","current":-95.63599,"twenty":-97.370352,"median":-95.274818,"eighty":-91.140058,"marketCap":99960000},{"date":"2025-05-09","current":-97.825684,"twenty":-105.935787,"median":-96.339196,"eighty":-91.340215,"marketCap":103320000},{"date":"2025-05-16","current":-84.217807,"twenty":-100.201018,"median":-95.63599,"eighty":-90.926742,"marketCap":101244000},{"date":"2025-05-23","current":-80.581767,"twenty":-98.816165,"median":-93.626109,"eighty":-84.541379,"marketCap":97383000},{"date":"2025-05-30","current":-84.00813,"twenty":-98.268761,"median":-91.426504,"eighty":-81.435196,"marketCap":101887500},{"date":"2025-06-06","current":-96.311865,"twenty":-97.862926,"median":-91.153997,"eighty":-82.722432,"marketCap":116902500},{"date":"2025-06-13","current":-100.074473,"twenty":-99.373354,"median":-91.49587,"eighty":-83.716948,"marketCap":122050500},{"date":"2025-06-20","current":-97.809905,"twenty":-99.60706,"median":-93.000433,"eighty":-84.092001,"marketCap":118404000},{"date":"2025-06-27","current":-102.489685,"twenty":-101.494097,"median":-95.486734,"eighty":-84.379593,"marketCap":125482500},{"date":"2025-07-03","current":-120.854919,"twenty":-102.248897,"median":-96.311865,"eighty":-84.935698,"marketCap":148005000},{"date":"2025-07-11","current":-124.985474,"twenty":-106.007618,"median":-97.137822,"eighty":-86.349331,"marketCap":152295000},{"date":"2025-07-18","current":-132.572254,"twenty":-114.154514,"median":-97.825684,"eighty":-87.117803,"marketCap":160875000},{"date":"2025-07-25","current":-135.657105,"twenty":-120.766208,"median":-98.637807,"eighty":-87.723817,"marketCap":165808500},{"date":"2025-08-01","current":-141.457084,"twenty":-127.052533,"median":-100.074473,"eighty":-88.142008,"marketCap":170098500},{"date":"2025-08-08","current":-147.065947,"twenty":-132.084845,"median":-100.877108,"eighty":-88.746909,"marketCap":178571250},{"date":"2025-08-15","current":-165.960185,"twenty":-135.719155,"median":-101.864899,"eighty":-90.454067,"marketCap":201630000},{"date":"2025-08-22","current":-19.835943,"twenty":-135.156914,"median":-100.877108,"eighty":-87.117803,"marketCap":24024000},{"date":"2025-08-29","current":-16.20864,"twenty":-133.03937,"median":-100.074473,"eighty":-84.050065,"marketCap":19714695},{"date":"2025-09-05","current":-13.797183,"twenty":-132.572254,"median":-98.793721,"eighty":-80.75926,"marketCap":16688100},{"date":"2025-09-12","current":-23.075466,"twenty":-132.572254,"median":-97.872236,"eighty":-79.695389,"marketCap":28099500},{"date":"2025-09-19","current":-25.731341,"twenty":-130.135208,"median":-97.233243,"eighty":-25.731341,"marketCap":31317000},{"date":"2025-09-26","current":-18.140867,"twenty":-129.914478,"median":-96.635856,"eighty":-24.673889,"marketCap":21879000},{"date":"2025-10-03","current":-19.511516,"twenty":-128.578436,"median":-95.486734,"eighty":-22.059467,"marketCap":23595000},{"date":"2025-10-10","current":-19.296452,"twenty":-127.569298,"median":-93.000433,"eighty":-19.880741,"marketCap":23166000},{"date":"2025-10-17","current":-16.568672,"twenty":-124.985474,"median":-91.46624,"eighty":-19.296452,"marketCap":19980675},{"date":"2025-10-24","current":-16.06721,"twenty":-123.273224,"median":-91.119148,"eighty":-18.49657,"marketCap":19302855},{"date":"2025-10-31","current":-15.732349,"twenty":-121.198249,"median":-88.359509,"eighty":-17.812248,"marketCap":18876000},{"date":"2025-11-07","current":-15.141189,"twenty":-120.854919,"median":-87.31095,"eighty":-17.344865,"marketCap":18103800},{"date":"2025-11-14","current":-13.600558,"twenty":-120.411362,"median":-84.622272,"eighty":-16.944742,"marketCap":16336320},{"date":"2025-11-21","current":-12.800811,"twenty":-120.018546,"median":-83.644152,"eighty":-16.763534,"marketCap":15283125},{"date":"2025-11-28","current":-11.798329,"twenty":-116.433192,"median":-81.32254,"eighty":-16.430432,"marketCap":14195610},{"date":"2025-12-05","current":-11.573043,"twenty":-114.518689,"median":-79.76251,"eighty":-16.194189,"marketCap":13942500},{"date":"2025-12-12","current":-4.842328,"twenty":-113.82561,"median":-79.605049,"eighty":-15.778958,"marketCap":10617750},{"date":"2025-12-19","current":-4.687446,"twenty":-110.341216,"median":-28.536071,"eighty":-15.100715,"marketCap":10296000},{"date":"2025-12-26","current":-4.652928,"twenty":-108.691185,"median":-25.601199,"eighty":-14.245656,"marketCap":10265970},{"date":"2026-01-02","current":-3.897664,"twenty":-107.357851,"median":-24.927609,"eighty":-13.667122,"marketCap":8582145},{"date":"2026-01-09","current":-4.569339,"twenty":-105.851045,"median":-23.442608,"eighty":-13.151367,"marketCap":10066485},{"date":"2026-01-16","current":-4.493076,"twenty":-104.268007,"median":-22.059467,"eighty":-12.515164,"marketCap":9877725},{"date":"2026-01-23","current":-4.404947,"twenty":-102.576358,"median":-20.19282,"eighty":-11.975184,"marketCap":9734010},{"date":"2026-01-30","current":-4.507689,"twenty":-102.44953,"median":-19.858342,"eighty":-11.545796,"marketCap":10081500},{"date":"2026-02-05","current":-4.00741,"twenty":-102.288908,"median":-19.551508,"eighty":-11.313324,"marketCap":8910330}],"updateTime":1770430576899},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CUPR\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2590341800","title":"Cuprina Holdings Forms Joint Venture With Aiodine Laboratory for Iodine-Based Wound Treatments","url":"https://stock-news.laohu8.com/highlight/detail?id=2590341800","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590341800?lang=en_us&edition=fundamental","pubTime":"2025-12-09 21:30","pubTimestamp":1765287031,"startTime":"0","endTime":"0","summary":"Cuprina Holdings  Ltd. has entered into a joint venture agreement with Singapore-based Aiodine Laboratory to develop, test, and market Aiodine's iodine-based disinfectant solution for use in treating chronic and acute wounds, as well as for applications such as disinfectants and home-use antiseptics. Additionally, Cuprina has signed a Memorandum of Understanding with Singapore Biowaste Solutions Pte Ltd  to explore integrating Cuprina's medical waste recycling technology into SBS's waste management facility in Singapore.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cuprina Holdings  Ltd. published the original content used to generate this news brief via GlobeNewswire  on December 09, 2025, and is solely responsible for the informati","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251209:nNDL9Fmv66:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014013.SGD","LU2095319765.USD","LU2210149790.SGD","IE00BKPKM429.USD","LU0314104364.USD","IE00B3QW5Z07.USD","BK4112","SG9999014005.SGD","SG9999014039.USD","CUPR","BK4585","BK4198","IE00BGHQF748.EUR","LU2210150020.SGD","SG9999014021.USD","NDAQ","IE00B64PRP62.GBP","BK4588"],"gpt_icon":0},{"id":"2590434123","title":"Cuprina Holdings (Cayman) Limited Announces Financial Results for the Six Months Ended June 30, 2025, and Strategic Initiatives for 2026 Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2590434123","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590434123?lang=en_us&edition=fundamental","pubTime":"2025-12-09 21:30","pubTimestamp":1765287000,"startTime":"0","endTime":"0","summary":"SINGAPORE, Dec.  09, 2025  (GLOBE NEWSWIRE) -- Cuprina Holdings (Cayman) Limited (Nasdaq: CUPR) (“Cuprina” or “the Company”), a biomedical company developing and marketing products for the chronic wou","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/12/09/3202369/0/en/Cuprina-Holdings-Cayman-Limited-Announces-Financial-Results-for-the-Six-Months-Ended-June-30-2025-and-Strategic-Initiatives-for-2026-Growth.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0122379950.USD","LU2089284900.SGD","LU1989764748.USD","LU0320765489.SGD","LU0265550946.USD","SBS","LU1023059063.AUD","LU0158827948.USD","LU1506573853.SGD","LU2028103732.USD","LU0072461881.USD","LU2111349929.HKD","LU1571399168.USD","LU1116320901.HKD","LU2089984988.USD","LU0211326755.USD","LU2089283258.USD","BK4588","LU0265550359.USD","LU0496365809.HKD","LU2271345857.HKD","BK4082","LU1989764664.SGD","IE00BFXG1179.USD","LU1116320737.USD","LU0158827781.USD","LU1989771016.USD","LU1057294990.SGD","LU0432979614.USD","LU1244550577.SGD","LU0314106906.USD","LU1244550221.USD","IE00BQXX3F31.USD","IE000M9KFDE8.USD","MDT","CUPR","BK4126","GEF","LU2112291526.USD","LU0976567544.SGD","BK4172","LU2468319806.SGD","LU1291159041.SGD","BK4566","LU0211331839.USD","LU2023251221.USD","IVF","IE00B1B80R65.USD","LU0211326839.USD","LU1983299246.USD"],"gpt_icon":0},{"id":"2586780855","title":"Cuprina Holdings (Cayman) Limited Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency","url":"https://stock-news.laohu8.com/highlight/detail?id=2586780855","media":"GlobeNewswire","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586780855?lang=en_us&edition=fundamental","pubTime":"2025-11-28 21:30","pubTimestamp":1764336600,"startTime":"0","endTime":"0","summary":"SINGAPORE, Nov.  28, 2025  (GLOBE NEWSWIRE) -- Cuprina Holdings (Cayman) Limited (Nasdaq: CUPR) (“Cuprina” or “the Company”), a biomedical company developing and marketing products for the chronic wou","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/28/3196279/0/en/Cuprina-Holdings-Cayman-Limited-Announces-Receipt-of-Nasdaq-Notification-Letter-Regarding-Minimum-Bid-Price-Deficiency.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["A","LU2089279066.USD","CUPR","LU2041044095.USD","QID","QLD","BK4588","BK4585","TQQQ","NQmain","LU0347712357.USD","MNQmain","USAW.SI",".IXIC","IE00BN0W2V16.EUR","LU2092937221.SGD","PSQ","IE00BN0W2T93.GBP","LU2229751404.USD","BK4198","IE00BN0W2W23.USD","SQQQ","LU1721428933.USD","BK4567","LU2413666699.HKD","BK4121","NVIW.SI","USJW.SI","LU2413666426.HKD","LU1165135440.EUR","TSYW.SI","LU1543694498.USD"],"gpt_icon":1},{"id":"2584927419","title":"Cuprina Forms Joint Venture Company With Aiodine Laboratory To Develop And Market Novel Iodine-Based Solution As New Wound Care Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2584927419","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584927419?lang=en_us&edition=fundamental","pubTime":"2025-11-20 01:58","pubTimestamp":1763575084,"startTime":"0","endTime":"0","summary":"Cuprina Holdings (Cayman) Ltd ::*CUPRINA FORMS JOINT VENTURE COMPANY WITH AIODINE LABORATORY  TO DEVELOP AND MARKET NOVEL IODINE-BASED SOLUTION AS NEW WOUND CARE THERAPY*CUPRINA HOLDINGS (CAYMAN) LTD ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251119:nRSD681LYm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4198","CUPR"],"gpt_icon":0},{"id":"2584307289","title":"Cuprina Holdings Forms Joint Venture with Aiodine Laboratory to Develop Iodine-Based Wound Care Solution","url":"https://stock-news.laohu8.com/highlight/detail?id=2584307289","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584307289?lang=en_us&edition=fundamental","pubTime":"2025-11-18 21:30","pubTimestamp":1763472626,"startTime":"0","endTime":"0","summary":"Cuprina Holdings  Ltd. has entered into a joint venture agreement with Singapore-based Aiodine Laboratory Pte Ltd. to develop, test, and market a novel iodine-based disinfectant solution for wound care and antiseptic applications. Under the agreement, Cuprina will oversee global sales, marketing, and distribution, while Aiodine Laboratory will provide proprietary iodine technology and technical expertise. The initial focus will be on wound care formulations, disinfectants, and daily antiseptics, with additional opportunities in personal care, oral hygiene, and veterinary applications under evaluation. Clinical studies for regulatory approval are planned to begin in 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cuprina Holdings  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251118:nNDL1KFSXS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2095319765.USD","LU2210149790.SGD","IE00BKPKM429.USD","LU0314104364.USD","IE00B3QW5Z07.USD","BK4112","CUPR","BK4585","BK4198","IE00BGHQF748.EUR","LU2210150020.SGD","NDAQ","IE00B64PRP62.GBP","BK4588"],"gpt_icon":0},{"id":"2584930290","title":"Cuprina Holdings (Cayman) Ltd - Clinical Studies for Regulatory Approvals Planned for 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2584930290","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584930290?lang=en_us&edition=fundamental","pubTime":"2025-11-18 21:30","pubTimestamp":1763472602,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251118:nTUA3Z9GQR:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4198","CUPR"],"gpt_icon":0},{"id":"2578939642","title":"BRIEF-Cuprina Signs MoU With Singapore Biowaste Solutions  To Integrate Medical Waste Management Technologies","url":"https://stock-news.laohu8.com/highlight/detail?id=2578939642","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578939642?lang=en_us&edition=fundamental","pubTime":"2025-10-27 21:43","pubTimestamp":1761572604,"startTime":"0","endTime":"0","summary":"BRIEF-Cuprina Signs MoU With Singapore Biowaste Solutions  To Integrate Medical Waste Management TechnologiesCuprina Holdings (Cayman) Ltd CUPR.O:CUPRINA SIGNS MOU WITH SINGAPORE BIOWASTE SOLUTIONS  T","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251027:nFWN3W81N8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CUPR","BK4198"],"gpt_icon":0},{"id":"2578564956","title":"Cuprina Signs Mou With Singapore Biowaste Solutions  to Integrate Medical Waste Management Technologies","url":"https://stock-news.laohu8.com/highlight/detail?id=2578564956","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578564956?lang=en_us&edition=fundamental","pubTime":"2025-10-27 20:40","pubTimestamp":1761568812,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251027:nFWN3W81N8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4198","CUPR"],"gpt_icon":0},{"id":"2573672286","title":"Cuprina Holdings (Cayman) Ltd. to Present and Answer Investor Questions Live at Skyline Signature Series™ Event","url":"https://stock-news.laohu8.com/highlight/detail?id=2573672286","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573672286?lang=en_us&edition=fundamental","pubTime":"2025-10-06 20:30","pubTimestamp":1759753817,"startTime":"0","endTime":"0","summary":"Cuprina Holdings  Ltd. , a biomedical and biotechnology company focused on products for chronic wound and infertility management as well as cosmeceuticals, will present at the Skyline Signature Series on Wednesday, October 8, 2025, at 11:00 AM ET. The company's management team, including CEO David Quek, will answer questions from investors during the live, interactive online event.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cuprina Holdings  Ltd. published the original content used to generate this news brief via GlobeNewswire  on October 06, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251006:nNDLc2m2VV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","LU2095319765.USD","BK4112","IE00B64PRP62.GBP","IE00BKPKM429.USD","LU0314104364.USD","CUPR","IE00B3QW5Z07.USD","LU2210150020.SGD","BK4585","BK4588","LU2210149790.SGD","NDAQ","BK4198"],"gpt_icon":0},{"id":"2566079706","title":"Nasdaq Surges Over 100 Points; Chewy Shares Fall After Q2 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2566079706","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566079706?lang=en_us&edition=fundamental","pubTime":"2025-09-10 22:20","pubTimestamp":1757514013,"startTime":"0","endTime":"0","summary":" ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"057452b93f5200ad30c849dac71497a8","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/market-summary/25/09/47597618/nasdaq-surges-over-100-points-chewy-shares-fall-after-q2-results","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0314104364.USD","TSYW.SI","IE00BGHQF748.EUR","BK4548","NVIW.SI","NDAQ","LU2210149790.SGD","CUPR","LU1941712264.USD","BK4547","BK4200","MWYN","BK4009","BK4588","BK4104","BK4112",".IXIC","BK4120","IE00B64PRP62.GBP","LU1941712348.USD","PCOM","BK4122","LU1169590202.USD","LU2095319765.USD","IE00B3QW5Z07.USD","BK4585","BK4170","SQQQ","USJW.SI","CHWY","MNQmain","QID","USAW.SI","YYGH","PSQ","QLD","BK4198","IE00BKPKM429.USD","LU1169589451.USD","BK4159","EPSM","LU2210150020.SGD","TQQQ","NQmain","WLDS"],"gpt_icon":1},{"id":"2566692574","title":"Cuprina Holdings (Cayman) Ltd: License With Zhejiang Heliang Covers Singapore + Option for 10 Sea Countries","url":"https://stock-news.laohu8.com/highlight/detail?id=2566692574","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566692574?lang=en_us&edition=fundamental","pubTime":"2025-09-09 20:10","pubTimestamp":1757419808,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250909:nFWN3UW0EM:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4198","CUPR"],"gpt_icon":0},{"id":"2566568692","title":"Cuprina Holdings (Cayman) Ltd: Secures Exclusive Rights to Southeast Asia’s First Medical Waste Recycling Technology","url":"https://stock-news.laohu8.com/highlight/detail?id=2566568692","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566568692?lang=en_us&edition=fundamental","pubTime":"2025-09-09 20:10","pubTimestamp":1757419808,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250909:nFWN3UW0EM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4198","CUPR"],"gpt_icon":0},{"id":"2566757694","title":"Cuprina Holdings Secures Exclusive Rights to Pioneering Medical Waste Recycling Technology in Southeast Asia","url":"https://stock-news.laohu8.com/highlight/detail?id=2566757694","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566757694?lang=en_us&edition=fundamental","pubTime":"2025-09-09 20:01","pubTimestamp":1757419289,"startTime":"0","endTime":"0","summary":"Cuprina Holdings  Ltd., a company specializing in biomedical and biotechnology products, announced it has secured exclusive licensing rights to Southeast Asia's first medical waste recycling technology, developed under the United Nations Industrial Development Organization  and Global Environment Facility . This technology, validated over two decades, offers an environmentally friendly alternative to incineration by using advanced high-temperature steam treatment to sterilize and decontaminate medical waste. Cuprina plans to construct a facility in Singapore to implement this technology, aiming to lead the region's transition to more sustainable waste management practices and capture growth opportunities as environmental standards tighten across Southeast Asia.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250909:nNDLv6bfG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4198","CUPR"],"gpt_icon":0},{"id":"2560902995","title":"Cuprina Holdings (Cayman) Ltd - Unaware of Reasons for Stock Volatility","url":"https://stock-news.laohu8.com/highlight/detail?id=2560902995","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560902995?lang=en_us&edition=fundamental","pubTime":"2025-08-18 20:00","pubTimestamp":1755518456,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250818:nFWN3UA066:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4198","CUPR"],"gpt_icon":0},{"id":"2560902510","title":"Cuprina Holdings (Cayman) Ltd - Responds to UnUsUaL Trading Activity","url":"https://stock-news.laohu8.com/highlight/detail?id=2560902510","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560902510?lang=en_us&edition=fundamental","pubTime":"2025-08-18 20:00","pubTimestamp":1755518456,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250818:nFWN3UA066:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4198","CUPR"],"gpt_icon":0},{"id":"2560616902","title":"Cuprina Holdings (Cayman) Ltd. reagiert auf jüngste Kursbewegungen der eigenen Aktie","url":"https://stock-news.laohu8.com/highlight/detail?id=2560616902","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560616902?lang=en_us&edition=fundamental","pubTime":"2025-08-18 20:00","pubTimestamp":1755518432,"startTime":"0","endTime":"0","summary":"Cuprina Holdings  Ltd. hat auf die jüngsten ungewhnlichen Kursbewegungen ihrer Aktie reagiert. Das Unternehmen betont, dass es sich in einer gesunden operativen Position befindet und keine betrieblichen Gründe für die Volatilitt bekannt sind. Cuprina bleibt fokussiert auf die Entwicklung ihrer Biotherapeutika und das Wachstum ihres Marktanteils. Keiner der anfnglichen Aktionre oder Gründungsmitglieder hat in der letzten Woche Aktien verkauft, was das Vertrauen in die langfristigen Wachstumschancen des Unternehmens unterstreicht.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cuprina Holdings  Ltd. published the original content used to generate this news brief via GlobeNewswire  on August 18, 2025, and is solely responsible for the inf","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250818:nNDL5V4YsF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKPKM429.USD","BK4112","IE00B64PRP62.GBP","LU2210149790.SGD","LU0314104364.USD","IE00B3QW5Z07.USD","IE00BGHQF748.EUR","BK4585","LU2210150020.SGD","BK4198","NDAQ","CUPR","LU2095319765.USD","BK4588"],"gpt_icon":0},{"id":"2559943558","title":"BUZZ-U.S. STOCKS ON THE MOVE-Xcel Energy, Opendoor Technologies, Advance Auto Parts","url":"https://stock-news.laohu8.com/highlight/detail?id=2559943558","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559943558?lang=en_us&edition=fundamental","pubTime":"2025-08-16 01:45","pubTimestamp":1755279913,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Xcel Energy, Opendoor Technologies, Advance Auto PartsEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning N","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250815:nL6N3U70DY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LEN","LNG","BK4577","FSLR","CCIRU","SLB","GTN","DHI","TGT","FANG","BK4505","LU1989773731.SGD","GEV","AMTD","PGEN","LU2458330169.SGD","SG9999002224.SGD","SLNO","EE","IE00B29SXK94.USD","RUN","TWLO","LU0889566641.SGD","LVWR","EQT","LRCX","LU0326950275.SGD","ONMD","OVV","XEL","KLAC","ENPH","CCIR","COF","AAP","GLOB","PPSI","FLYE","OPEN","09999","TE","CNX","CUPR"],"gpt_icon":1},{"id":"2553477068","title":"Cuprina Signs Agreement to Market Medical Maggots for Debridement Therapy in US","url":"https://stock-news.laohu8.com/highlight/detail?id=2553477068","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553477068?lang=en_us&edition=fundamental","pubTime":"2025-07-21 21:59","pubTimestamp":1753106385,"startTime":"0","endTime":"0","summary":"Cuprina  said Monday it has signed an agreement to acquire the right to market medical maggots for use in debridement therapy to treat chronic wounds in the US.The agreement was signed with Ronald Sherman, who holds a 2004 US Food and Drug Administration clearance to market Lucilia sericata maggots, giving Cuprina the right to manufacture, sell, use, and distribute the medical maggots and associated dressings for maggot debridement therapy, according to a statement.Sherman will join the company as medical and scientific director in September, Cuprina said.Cuprina also said it is updating a submission to the FDA to seek approval for the use of another species of medical maggots, Lucilia cuprina, and could receive marketing clearance within 90 business days.Price: 7.55, Change: -0.02, Percent Change: -0.26","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CUPR","BK4198"],"gpt_icon":0},{"id":"2553747235","title":"Cuprina Holdings Appoints Dr. Ronald Sherman as Medical and Scientific Director, Enhancing Leadership in Maggot Debridement Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2553747235","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553747235?lang=en_us&edition=fundamental","pubTime":"2025-07-21 21:00","pubTimestamp":1753102827,"startTime":"0","endTime":"0","summary":"Cuprina Holdings Appoints Dr. Ronald Sherman as Medical and Scientific Director, Enhancing Leadership in Maggot Debridement Therapy. Cuprina Holdings  Ltd. has appointed Dr. Ronald A. Sherman as Medical and Scientific Director, effective September 2025. Dr. Sherman, known for his work in medical maggot therapies, will provide clinical leadership and guidance on bio-therapeutics, and assist in developing a training framework for clinicians. Cuprina is updating its FDA submission for Lucilia cuprina maggots, aiming to secure a second U.S. FDA clearance for maggot debridement therapy.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cuprina Holdings  Ltd. published the original content used to generate this news brief via GlobeNewswire  on ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250721:nNDL1CHhy5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","LU2095319765.USD","LU2210150020.SGD","CUPR","BK4112","IE00B3QW5Z07.USD","LU2210149790.SGD","BK4198","NDAQ","BK4588","IE00B64PRP62.GBP","BK4585","IE00BKPKM429.USD"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":19,"code":"91000000","status":"200"}]}}